Wall Street mixed on wednesday, UK approves Pfizer’s COVID vaccine

Swissquote Bank Research Team Swissquote Bank Ltd

US equities were mixed on Wednesday, with the S&P 500 updating the record high for a second straight session, while the Nasdaq closing in the red. The market was driven by positive COVID vaccine news and stimulus talks. The downbeat private jobs data triggered stronger resistance.

Democrats and Republicans in Congress failed to reach consensus on fresh stimulus, though some analysts argue that bad economic reports might urge policymakers to insist on a deal. US House Majority Leader Steny Hoyer said that an agreement might be reached in the next few days.

ADP data showed that private payrolls rose less than anticipated last month, as the resurgence of the pandemic forced the US government to introduce new restrictive measures that affected many businesses. On Friday, the nonfarm payrolls report might be decisive in convincing Congress that fresh stimulus is needed.

Investor sentiment was buoyed by the latest vaccine news, as the UK was the first Western country to approve a COVID vaccine. Britain gave the nod to the vaccine developed by Pfizer and BioNTech. The stock price of the two rose by 3.5% and 6%, respectively.

The vaccine optimism doesn't really help tech stocks, which benefited during the whole lockdown period at the expense of value stocks. Nasdaq fell 0.05%. Elsewhere, the S&P 500 and the Dow ended higher, up 0.18% and 0.20%, respectively.

In Asia, stocks are mixed in early trading on Thursday, but bulls dominate on the back of vaccine optimism and potential US stimulus.

At the time of writing, China's Shanghai Composite is down 0.46%, while the Shenzhen Component has gained 0.09%. The market was driven by upbeat services sector data. Caixin said that its services PMI for November came in at 57.8, topping estimates of a 56.5 reading and up from 56.8 in October. New business rose at the fastest rate in about 10 years.

However, deteriorating tensions between the US and China are putting pressure on the Chinese market. The US House of Representative green-lighted legislation that allows Chinese firms, such as Alibaba, to be dismissed from US exchanges if they don't allow regulators to review their financial performance.

Also, the Trump administration banned cotton imports from a major Chinese quasi-military organization. The US argues that the company used forced labor of Uighur Muslims that are detained.

Hong Kong's Hang Seng Index was up 0.77%.

Japan's Nikkei 225 inched higher by 0.04%. The country's services PMI rose to 47.8 in November, after October's figure at 47.7.

South Korea's KOSPI is up 0.64%. In Australia, the ASX 200 closed 0.38% higher.

In the commodity market, oil prices are declining amid a wobbling week. The WTI is down 0.42%, and Brent lost over 0.30%. OPEC+ is resuming talks regarding a potential extension of the crude production cuts after the current deadline of January 2021. Some members question further cuts as they argue that prices have been pushed up by the vaccine news.

Gold continues to recover, despite the optimism surrounding the COVID vaccine. The metal is up 0.28% to $1,835.

In FX, the US dollar continues to decline on hopes for fresh stimulus and expectations that the vaccine developed by Pfizer would speed up economic recovery. The USD Index broke below 91.00 for the first time since April 2018. EUR/USD is up 0.03% to 1.2119.

The pound is gaining traction versus both the US dollar and the euro, as the UK became the first developed country to approve a COVID vaccine. Previously, the sterling was under increased pressure on the back of mixed signals about Brexit talks, which entered their decisive week.

Stay on top of the markets with Swissquote’s News & Analysis

Author

Swissquote Bank Research Team

Swissquote Bank Ltd

EUR/USD accelerates losses, focus is on 1.1800

EUR/USD’s selling pressure is gathering pace now, opening the door to a potential test of the key 1.1800 region sooner rather than later. The pair’s pullback comes on the back of marked gains in the US Dollar following US data releases and the publication of the FOMC Minutes later in the day.

GBP/USD turns negative near 1.3540

GBP/USD reverses its initial upside momentum and is now adding to previous declines, revisiting at the same time the 1.3540 region on Wednesday. Cable’s downtick comes on the back of decent gains in the Greenback and easing UK inflation figures, which seem to have reinforced the case for a BoE rate cut in March.

Gold picks pace, flirts with $5,000

Gold is back on the front foot on Wednesday, shaking off part of the early week softness and pushing higher towards the key $5,000 mark per troy ounce. The move comes ahead of the FOMC Minutes and is unfolding despite an intense rebound in the US Dollar.

Fed Minutes to shed light on January hold decision amid hawkish rate outlook

The Minutes of the Fed’s January 27-28 monetary policy meeting will be published today. Details of discussions on the decision to leave the policy rate unchanged will be scrutinized by investors.

Mixed UK inflation data no gamechanger for the Bank of England

Food inflation plunged in January, but service sector price pressure is proving stickier. We continue to expect Bank of England rate cuts in March and June. The latest UK inflation read is a mixed bag for the Bank of England, but we doubt it drastically changes the odds of a March rate cut.

Sui extends sideways action ahead of Grayscale’s GSUI ETF launch

Sui is extending its downtrend for the second consecutive day, trading at 0.95 at the time of writing on Wednesday. The Layer-1 token is down over 16% in February and approximately 34% from the start of the year, aligning with the overall bearish sentiment across the crypto market.